It may be that after today’s announcement that bears of THG (THG) feel that they may be on the wrong side of the price action. The company said CEO Matthew Moulding, has confirmed his intention to cancel his Special Share rights. This cancellation will facilitate the Group’s application to step-up to the Premium segment of the Main Market of the London Stock Exchange in 2022.
By Zak mir
There was some A Lister coverage in the Sunday Telegraph for clinical research group Open Orphan (ORPH), one of the clear stock market winners of the past couple of years. Under the headline of “Inside the London lab company infecting humans with Covid” we learned in the article that the company is the only one in the world running human challenge studies with coronavirus.
Another day, another update from Oracle Power (ORCP) where the fundamentals appear to be revving up. The company announced it now has Oracle now has multiple high growth divisions and prospects, with the support and cooperation of two state-owned Chinese enterprises and a highly supportive strategic shareholder. Oracle said it is pursuing power generation in Pakistan and is working to prove up two highly prospective gold properties in Western Australia, creating a group of assets and interests which can generate significant returns for its investors.
It is perhaps surprising that after the recent M&A moves it is not the punters so much making a beeline for podcaster Audioboom (BOOM), but its management. Michael Tobin OBE, non-executive Chairman of the Company, purchased 1,904 shares at 1,050p. Tobin now holds approximately 2% of the shares.
Dev Clever (DEV), the online and immersive career guidance and development group, said that its wholly-owned Indian subsidiary and Veative Labs Pvt Ltd have agreed a material extension to their partnership with the CSC Academy in India. In June the company stated that its immersive learning and careers platform would go live in 25 of the c. 5,930 CSC academy centres and it would assess the foundation programme of STEM-based immersive learning and careers guidance.
Asimilar Group (ASLR), the AIM quoted investing company, noted the announcement made this morning by Dev Clever Holdings. Asimilar has an interest in 76 million shares of Dev Clever and 35 million unexercised warrants with an exercise price of 25p, versus 36p on Friday.
Hemogenyx Pharmaceuticals (HEMO) said it has signed a lease with The Janus Property Company for a new custom-designed and built laboratory in the Mink Building, located in the Manhattanville Factory District of New York, adjacent to Columbia University and City College. The company’s new lab will allow it to pursue commercialisation of its major cell therapy product candidates by manufacturing cells in-house, starting with its HEMO-CAR-T cell therapy for the treatment of acute myeloid leukemia.
Aquis listed Quetzal Capital (QTZ) announced audited final results for the 12 month period ended 30 June 2021. They showed a loss of £71,915 compared to a profit for the same period in 2020 of £275,963. The profit recorded in 2020 was attributable to the write-off of historic debt by creditors in June 2020. The net assets as at 30 June 2021 were £3,160,034 (2020: (£41,557)), so still decent cash in the kitty future developments, that its investors are waiting on.
Thor Mining (THR) advised on the results from its initial pump test for preliminary hydrogeological assessment at the Alford East Copper-Gold Project, SA. Here the initial aquifer pump test has been successfully completed. Copper-gold mineralisation at the test site is saturated below the water table, essential for ISR production.
Bradda Head Lithium (BHL), the North America-focused lithium development group, has joined the rush of UK companies seeking to broaden its liquidity pool. It said that it has started the process to list on the US OTC Markets platform. The company’s shares will be cross-traded on the OTCQB Board of the OTC Markets. This listing will be in addition to the existing quoting on the AIM of the Stock Exchange in London.
Corcel (CRCL), the natural resource exploration and development company, announced that it has completed the share purchase agreement with Australian-registered Resource Mining Corporation Limited (ASX: RMI) to acquire 100% of the issued share capital in Australian-registered Niugini Nickel Pty Ltd, which owns 100% of the Wo Wo Gap nickel-cobalt project in Papua New Guinea.
Dispersion (DEFI), an incubator specialising in decentralised finance, revealed the proposed acquisition of Accru Finance Ltd, which plans to launch the first internationally-regulated and insured platform for the trading and yield farming of cryptocurrencies, for a consideration of £8.75m to be paid for by the issue of 250 million new ordinary shares in Dispersion. The acquisition is the biggest corporate investment by the company since its IPO.
HydrogenOne Capital Growth (HGEN), the London listed hydrogen fund, announced that it has today signed definitive agreements for its first private equity investment of €24m (£20m) in Sunfire GmbH, a leading electrolyser producer, for a minority equity stake. HydrogenOne has the right to a board observer seat at Sunfire, and intends to collaborate with Sunfire on the roll-out of future hydrogen manufacturing projects.
ReNeuron Group (RENE), a developer of cell-based therapeutics, provided a further update on the progress of its Phase 2a clinical evaluations for the treatment of retinitis pigmentosa, an inherited, degenerative eye disease. The company said that the first UK subject has been treated at the Oxford Eye Hospital, part of Oxford University Hospitals NHS Foundation Trust. The remaining study subjects are expected to be treated by the end of 2021.
Destiny Pharma (DEST), a clinical stage biotechnology company, said it notes the important study report presented at the leading international conference, IDWeek virtual meeting which took place on 30 September – 3 October 2021. The Phase 4 study was the largest ever of this type, with over 300,000 patients which explored the link between Staphylococcus aureus decolonisation and Intensive Care Units infection rates.
Castillo Copper Limited (CCZ), the base metal explorer, said that drilling has now commenced at the Arya Copper Prospect, located in the Mt Isa copper-belt of Queensland, Australia. The inaugural drilling campaign at the Arya Copper Prospect is now underway, after a massive logistical effort to prepare the drill-pads and heli-lift the rig and all supporting equipment to site. After reconciling the geochemical and geophysics data, the Board decided to orchestrate a strategic “proof of concept” campaign, comprising five initial RC drill-holes.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.
Terms of Website Use
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned